Myriad Genetics (NASDAQ:MYGN) VP Gary A. King sold 20,000 shares of Myriad Genetics stock on the open market in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $38.00, for a total value of $760,000.00. Following the completion of the transaction, the vice president now directly owns 2,949 shares in the company, valued at approximately $112,062. Myriad Genetics, Inc. (NASDAQ:MYGN) stock opened at $37.71 in last trading session, and closed at $38.14, trading in the range of $37.46 – $38.31. The stock showed a positive weekly performance of 21.31%.
Qiagen NV (NASDAQ:QGEN) stock has an average recommendation of Hold with an average target price of $17.14. Qiagen NV (NASDAQ:QGEN) shares closed at $22.34 on last trade day, by gaining 1.59%. Stock 52 week range is $18.30 – $24.82. Company’s market capitalization is $5.24 billion.
Forrester Research, Inc. (NASDAQ:FORR) stock has an average recommendation of Hold with an average target price of $39.00. Forrester Research, Inc. (NASDAQ:FORR) stock advanced 0.70% and finished the last session at $35.94. The EPS of the stock remained 0.61. Company’s market capitalization is $709.92 billion.
TheStreet cut shares of Bioanalytical System (NASDAQ:BASI) from a hold rating to a sell rating in a research report sent to investors on Friday morning, Analyst Ratings Net reports. Bioanalytical Systems, Inc. (NASDAQ:BASI) stock opened at $2.82 in last trading session and closed at $2.84. The 52 week range of the stock is $1.25 – $3.80 and the day range was $2.80 – $2.98.